introduction complex sphingolipids important component biomembranes eukaryotic cell involved various cellular function including lipid microdomain formation maintenance signal transduction system organelle homeostasis vesicular trafficking acquisition stress tolerance complex sphingolipids composed ceramides cer -acylated product sphingoid long-chain base lcbs hydrophilic head group molecular genetics approach using yeast saccharomyces cerevisiae contributed elucidation physiological importance complex sphingolipids first second step biosynthesis sphingolipids catalyzed lcb1 lcb2 serine palmitoyltransferase spt tsc10 3-ketodihydrosphingosine reductase respectively fig step essential yeast implying depletion sphingolipids cause lethal phenotype lack cer synthase gene lag1/lac1 regulatory subunit lip1 cause severe growth defect lethal probably trace level biosynthesis cer still occurs via unknown mechanism yeast three class complex sphingolipids inositolphosphorylceramide ipc mannosylinositol phosphorylceramide mipc mannosyldiinositol phosphorylceramide simplest structure complex sphingolipid ipcs fig lack aur1 encoding ipc synthase cause lethal phenotype reduction complex sphingolipid level accumulation cer contrast conversion ipcs mipcs mipcs doe cause cell growth defect indicating extension hydrophilic region complex sphingolipids essential however biosynthesis mipcs important maintenance endosomal trafficking cell wall integrity acquisition tolerance multiple environmental stress figure effect impaired biosynthesis ergosterol complex sphingolipid biosynthesis-defective condition biosynthesis pathway complex sphingolipids ergosterol budding yeast saccharomyces cerevisiae pathway protein involved biosynthesis step shown aureobasidin aba myriocin inhibit ipc synthase aur1 serine palmitoyltransferase spt respectively miconazole inhibits lanosterol 14-alpha-demethylase erg11 effect deletion erg2-6 repression expression aur1 tet-aur1 lcb1 tet-lcb1 lip1 ptetoff-lip1-1 cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration doxycycline dox effect deletion erg2-6 sensitivity aba myriocin cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration aba myriocin acquisition resistance aba presence miconazole cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration aba 0.15 µg/ml miconazole plate incubated photographed day detail given method full size image together complex sphingolipids ergosterol primary structure sterol budding yeast also important constituent factor formation lipid microdomains analysis genetic interaction gene involved biosynthesis complex sphingolipids ergosterol yeast indicated lipid function cooperatively comprehensive analysis deletion combination sphingolipid-metabolizing enzyme gene scs7 sur2 isc1 nonessential gene involved final step biosynthesis ergosterol erg2 erg3 erg4 erg5 erg6 revealed simultaneous impairment metabolism sphingolipids ergosterol cause multiple stress hypersensitivity furthermore synthetic lethal interaction due deletion erg6 elo3 encoding enzyme involved biosynthesis long-chain fatty acid used sphingolipid biosynthesis also reported addition impairment cell wall integrity due loss biosynthesis mipcs exacerbated repression expression erg9 encoding squalene synthase located middle stage ergosterol biosynthesis pathway moreover lethality caused cumulative mutation gene involved ergosterol biosynthesis suppressed mutation causing alteration composition complex sphingolipids supporting notion close functional relationship complex sphingolipids ergosterol aureobasidin aba cyclic depsipeptide anti-fungal antibiotic isolated black-yeast-like fungus aureobasidium pullulans r106 inhibits activity aur1 strong cytotoxic activity several gene associated determination sensitivity aba identified i.e atp-binding cassette transporter pdr5 yor1 involved determination aba sensitivity possibly indirectly directly involved efflux intracellularly accumulated aba addition deletion elo3 confers resistance aba without affecting alteration sphingolipid level due aba treatment resistance due deletion elo3 also observed expression level aur1 repressed tetracycline-regulatable promoter implying chain length fatty acid cer critical factor determination cytotoxic activity aba notion also supported fact deletion aur1 doe cause lethal phenotype endogenous cer synthases replaced one enzyme cotton cer containing c18 fatty acid produced instead c26-cers primary structure cer wild-type budding yeast study found impaired biosynthesis pathway ergosterol caused deletion erg6 erg2 erg5 cause resistance aba however effect observed repression expression aur1 deletion erg6 result suppression reduction complex sphingolipids accumulation cer aba treatment indicating deletion reduces effectiveness aba vivo aur1 activity moreover found acquisition aba resistance mediated pdr16 previously identified multicopy suppressor aba result indicate novel functional relationship complex sphingolipids ergosterol result effect defect ergosterol biosynthesis pathway growth defect caused impaired biosynthesis sphingolipids investigate functional relationship sphingolipids ergosterol nonessential gene involved final stage ergosterol biosynthesis pathway erg2 erg3 erg4 erg5 erg6 deleted sphingolipid biosynthesis repressed various mean fig c–g repress expression aur1 lcb1 used mutant strain carry aur1 lcb1 gene control tetracycline-regulatable tet promoter tet-aur1 tet-lcb1 expression repressed addition doxycycline dox ptetoff-lip1-1 cell also strain exhibit suppression expression lip1 addition dox orf sequence lip1 contains frameshift mutation thus mutant cell exhibit stronger inhibitory effect cer synthesis aur1 -repressive condition cell growth defect phenotype enhanced deletion one erg2-6 fig enhancement effect also observed erg2∆ erg3∆ erg5∆ erg6∆ lcb1- repressive condition fig erg2∆ erg4∆ erg6∆ lip1- repressive condition fig however cell treated aureobasidin aba inhibitor aur1 cell growth defect phenotype dramatically different observed repression expression gene involved sphingolipid metabolism deletion erg2 erg5 erg6 caused resistance aba fig effect erg2 erg6 aba sensitivity consistent previous report erg5∆ erg6∆ cell erg2∆ cell also exhibited resistance myriocin inhibitor serine palmitoyltransferase however effect much weaker compared aba fig notably treatment miconazole inhibitor lanosterol 14-alpha-demethylase erg11 concentration induce strong growth defect also confers resistance aba fig thus suggested impaired biosynthesis ergosterol confers resistance aba deletion erg6 reduces effectiveness aba vivo activity aur1 experiment focused deletion erg6 strongest effect aba sensitivity fig shown fig abnormal cell morphology observed aba-treated wild-type cell seem observed erg6∆ cell moreover appearance propidium iodide -positive cell presence aba greatly suppressed deletion erg6 suggesting suppression cell death fig inhibition activity aur1 cause reduction complex sphingolipid level accumulation cer believed lead cell growth defect caused inhibition thus next investigated whether erg6∆ affect alteration complex sphingolipid cer level caused aba treatment figure show time course cell presence aba growth wild-type cell began delayed around addition ng/ml aba however delay dramatically attenuated deletion erg6 thus decided measure complex sphingolipid cer level addition ng/ml aba reported previously aba treatment wild-type cell caused significant reduction level complex sphingolipids however erg6∆ cell reduction observed fig accumulated level cer-c due aba treatment dramatically suppressed deletion erg6 fig result indicated inhibitory effect aba biosynthesis ipcs suppressed deletion erg6 also examined effect erg6∆ alteration sphingolipid level repression expression aur1 tet promoter spot assay fig liquid culture deletion erg6 also confer resistance repression expression aur1 presence µg/ml dox fig shown fig reduction complex sphingolipid level indistinguishable dox-treated tet-aur1 tet-aur1 erg6∆ cell figure effect erg6∆ alteration sphingolipid level caused aba treatment repression expression aur1 time course growth aba-treated cell cell cultured overnight ypd medium diluted 0.05 units/ml fresh ypd medium incubated indicated concentration aba added culture aliquot cell suspension subjected cell density measurement indicated time tlc analysis complex sphingolipids cer-c cell cultured overnight ypd medium diluted 0.05 units/ml fresh ypd medium incubated treated ng/ml aba lipid extracted separated tlc complex sphingolipids cer-c quantified imagej software nih amount complex sphingolipids ipcs mipcs cer-c aba-untreated wild-type cell taken respectively original tlc plate presented fig s11 time course growth aur1 -repressed cell cell cultured overnight ypd medium diluted 0.018 units/ml fresh ypd medium incubated indicated concentration dox added culture cell density indicated time measured described cell cultured overnight ypd medium diluted 0.018 units/ml fresh ypd medium incubated treated µg/ml dox tlc analysis performed described amount complex sphingolipids ipcs mipcs dox-untreated tet-aur1 cell taken respectively original tlc plate presented fig s11 data represent mean one experiment triplicate representative three independent experiment detail given method full size image confirm effect erg6∆ vivo inhibitory activity aba toward aur1 c6-nbd-cer used exogenously added c6-nbd-cer incorporated yeast cell converted c6-nbd-ipc shown fig production c6-nbd-ipc wild-type erg6∆ cell inhibited addition aba concentration-dependent manner however effectiveness aba erg6∆ cell much weaker wild-type cell contrast inhibitory effect aba ipc synthase activity cell lysates differ wild-type erg6∆ cell fig thus suggested resistance aba due erg6∆ caused reduced effectiveness aba vivo aur1 activity figure erg6∆ affect vivo inhibition aur1 aba aur1 protein expression level localization conversion intracellularly incorporated nbd-cer nbd-ipc cell cultured overnight diluted 0.3 units/ml fresh ypd medium incubated cell unit suspended fresh ypd containing mg/ml fatty-acid free bsa ng/ml aba incubated nmol c6-nbd-cer added cell incubated min lipid extracted separated tlc amount c6-nbd-ipc aba-untreated wild-type cell taken original tlc plate presented fig s10 ipc synthase activity cell lysates wild-type erg6∆ cell presence indicated concentration aba measured using c6-nbd-cer substrate level c6-nbd-ipc generated c6-nbd-cer cell lysates wild-type erg6∆ cell absence aba taken respectively protein expression level aur1 kei1 cell expressing aur1-6xha kei1-6xha native promoter cultured overnight ypd medium diluted 0.3 units/ml fresh ypd medium incubated yeast cell extract immunoblotted using anti-ha anti-pgk1 amount tagged protein erg6 cell taken data represent mean one experiment triplicate representative three independent experiment original blot presented fig effect aba growth wild-type erg6∆ tet-aur1 tet-aur1 erg6∆ cell cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration aba cell expressing aur1-eqfp611 yegfp-gos1 cultured described gfp rfp fluorescence observed fluorescence microscopy incorporation efficiency aba cell cell cultured described cell unit suspended fresh ypd containing ng/ml aba incubated cell harvested aba extracted cell analyzed lc-esi ms/ms data represent mean one experiment triplicate representative three independent experiment detail given method full size image one possibility deletion erg6 cause increase protein expression level ipc synthase thus reduces efficiency aba however protein expression level aur1 kei1 essential component ipc synthase significantly different wild-type erg6∆ cell chromosomal aur1 kei1 tagged sequence encoding six copy hemagglutinin epitope 6xha tagged protein detected anti-ha antibody fig addition tet-aur1 cell exhibit constitutive expression aur1 due tet-promoter absence dox deletion erg6 also conferred aba resistance fig supporting notion erg6∆ doe cause resistance aba altered activity native promoter aur1 reported aur1 localized medial golgi confirmed aur1-eqfp611 colocalized medial golgi marker yegfp-gos1 fig colocalization altered deletion erg6 fig thus suggested deletion erg6 affect effectiveness aba vivo aur1 activity without alteration protein expression level subcellular localization aur1 examine whether deletion erg6 affect incorporation aba cell intracellular level aba cell treated ng/ml aba determined lc-esi ms/ms shown fig significant difference intracellular aba level aba-treated wild-type erg6∆ cell observed resistance aba due impaired biosynthesis ergosterol caused pdr16 -dependent manner previously reported overexpression pdr16 pdr17 encode protein belonging phosphatidylinositol transfer protein family pitp family confers resistance aba however overexpression doe suppress growth defect caused aur1 repression thus next investigated relationship erg6 pdr16/17 determination aba sensitivity shown fig aba resistance due erg6∆ completely abolished deletion pdr16 erg6∆ versus erg6∆ pdr16∆ cell however aba sensitivity wild-type pdr16∆ cell indistinguishable reduced resistance aba also observed deletion pdr17 erg6∆ versus erg6∆ pdr17∆ cell however effect much weaker pdr16 fig thus suggested pdr16 contributes aba resistance erg6∆ cell much pdr17 noted erg6∆ pdr16∆ cell exhibited higher aba sensitivity wild-type pdr16∆ cell fig furthermore experimental condition pdr17∆ cell exhibited higher aba sensitivity wild-type cell fig contrast compared effect deletion pdr16 pdr17 erg6 -deleted cell treated aba deletion pdr16 pdr17 weak effect cell growth erg6 -deleted tet-aur1 cell presence dox dox-treated tet-aur1 erg6∆ versus dox-treated tet-aur1 erg6∆ pdr16∆ tet-aur1 erg6∆ pdr17∆ cell fig aba resistance due deletion erg2 erg5 treatment miconazole also abolished deletion pdr16 fig suggesting acquisition resistance aba due impaired biosynthesis ergosterol biosynthesis depends pdr16 sensitivity myriocin also suppressed deletion erg5 erg6 fig however pdr16∆ slightly suppressed completely abolish myriocin resistance due erg5∆ erg6∆ fig plasma membrane-localized abc transporter involved attenuation cytotoxic effect various drug pdr5 yor1 involved determination sensitivity aba thus also examined whether aba resistance due deletion erg6 affected deletion gene encoding plasma membrane localized-abc transporter known function aus1 snq2 pdr10 pdr11 pdr12 pdr15 pdr5 yor1 pdr18 ste6 fig deletion pdr5 yor1 slightly altered aba sensitivity erg6 -deleted cell however strong aba resistance still observed gene notable effect observed erg6 -deleted cell fig figure effect deletion pdr16 and/or pdr17 cell defective ergosterol biosynthesis effect pdr16∆ and/or pdr17∆ aba sensitivity erg6 -deleted cell cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration aba effect combination deletion erg6 pdr16 pdr17 growth aur1 -repressed cell effect pdr16∆ aba sensitivity erg2 erg5 -deleted cell effect pdr16∆ miconazole-induced aba resistance effect deletion gene encoding plasma membrane-localized abc transporter known function erg6 -deleted cell detail given method full size image figure show effect deletion pdr16 and/or pdr17 alteration complex sphingolipid cer-c level due aba treatment although deletion erg6 caused suppression reduction complex sphingolipid level accumulation cer-c level presence aba wild-type versus erg6∆ cell significant difference sphingolipid level observed aba-treated pdr16∆ pdr16∆ erg6∆ cell fig deletion pdr17 also suppressed effect erg6 pdr17∆ versus pdr17∆ erg6∆ cell however effect much weaker pdr16 fig result consistent tendency seen aba sensitivity fig effect double deletion pdr16 pdr17 erg6 -deleted cell similar single deletion pdr16 significant difference observed pdr16∆ pdr17∆ pdr16∆ pdr17∆ erg6∆ cell alteration sphingolipid level due aba treatment fig thus suggested deletion pdr16 alone sufficient counteract suppressive effect aba deletion erg6 figure effect erg6∆ alteration sphingolipid level caused aba treatment abolished pdr16∆ tlc analysis complex sphingolipids cer-c cell cultured overnight ypd medium diluted 0.05 units/ml fresh ypd medium incubated treated ng/ml aba lipid extracted separated tlc complex sphingolipids cer-c quantified imagej software amount complex sphingolipids ipcs mipcs cer-c aba-untreated wild-type cell taken respectively effect double deletion pdr16 pdr17 original tlc plate presented fig s12 data represent mean one experiment triplicate representative three independent experiment detail given method full size image increase expression level pdr16 erg6 -deleted cell possible deletion erg6 increase expression level pdr16 and/or pdr17 thus confers aba resistance thus next examined protein expression level pdr16 pdr17 wild-type erg6∆ cell detection pdr16 pdr17 western blotting chromosomal pdr16 pdr17 tagged sequence encoding 6xha erg6∆ cell exhibited approximately increase protein expression level pdr16-6xha compared wild-type cell however significant difference pdr17-6xha observed wild-type erg6∆ cell fig aba treatment cause notable change pdr16-6xha pdr17-6xha expression level regardless erg6 deletion fig increase expression level pdr16 due erg6∆ also observed chromosomal pdr16 tagged sequence encoding yegfp fig promoter region chromosomal pdr16 replaced adh cyc1 promoter increase expression level pdr16-yegfp due erg6∆ still observed fig moreover promoter activity pdr16 increased rather slightly decreased deletion erg6 reporter gene plasmid contains potential promoter region pdr16 alpha-galactosidase gene used estimation fig result suggested increase protein expression level pdr16 due erg6∆ occurs posttranslationally pdr16 expressed control cyc1 promoter deletion erg6 caused resistance aba cyc1p-pdr16 versus cyc1p-pdr16 erg6∆ cell fig moreover cyc1p-pdr16 erg6∆ cell resistant aba wild-type cell even though expression level pdr16-yegfp cyc1 promoter much lower native promoter fig implying mechanism pdr16 -mediated aba resistance acquisition erg6 -deleted cell solely due increased pdr16 expression level adhp-pdr16 erg6∆ cell resistant aba wild-type cell however resistance weaker erg6∆ cell even though expression level pdr16-yegfp adh promoter higher native promoter fig suggested excessive pdr16 overexpression rather detrimental erg6 -deleted cell pdr16 primarily localized cytosol lipid droplet reported preferentially localized lipid droplet close nucleus-vacuole junction nvjs lipid droplet stained nile red localization pdr16-yegfp lipid droplet observed wild-type erg6 -deleted cell fig moreover wild-type erg6 -deleted cell pdr16-yegfp localized lipid droplet close eqfp611-tagged nvj1 involved formation nvj fig addition colocalization aur1-yegfp pdr16-eqfp69 observed wild-type erg6∆ cell fig result suggested localization pattern pdr16 affected deletion erg6 figure effect deletion erg6 protein expression level localization pdr16 protein expression level pdr16 pdr17 cell expressing pdr16-6xha pdr17-6xha native promoter cultured overnight ypd medium diluted 0.3 units/ml fresh ypd medium incubated yeast cell extract immunoblotted using anti-ha anti-pgk1 amount tagged protein erg6 cell taken data represent mean one experiment triplicate representative three independent experiment original blot presented fig cell expressing pdr16-yegfp cultured described gfp fluorescence observed fluorescence microscopy expression pdr16-yegfp native promoter cyc1 promoter adh promoter cell cultured described fluorescence intensity gfp individual cell measured flow cytometer value average fluorescence intensity 10,000 cell one sample fluorescence intensity pdr16-yegfp cell taken data represent mean three sample representative three independent experiment promoter activity pdr16 cell harboring prs415- pdr16p-mel1 cultured overnight medium lacking leucine sc-leu diluted 0.3 unit/ml fresh sc-leu medium incubated cell harvested alpha-galactosidase activity measured described method data represent mean one experiment triplicate representative three independent experiment effect erg6∆ aba sensitivity cell expressing pdr16 via native promoter cyc1 promoter adh promoter cell cultured overnight ypd medium spotted onto ypd plate without indicated concentration aba nile red staining cell expressing pdr16-yegfp cell cultured described stained µg/ml nile red min washed water observed fluorescence microscopy cell expressing pdr16-yegfp nvj1-eqfp611 cultured described gfp rfp fluorescence observed fluorescence microscopy detail given method full size image discussion study found impaired biosynthesis ergosterol includes deletion erg6 erg2 erg5 treatment miconazole cause pdr16-mediated resistance aba among pitp family protein sec14 sfh1 csr1 pdr16 pdr17 sfh5 pdr16 pdr17 confer strong resistance aba protein overexpressed however suppressive effect pdr17∆ aba resistance caused erg6∆ much weaker pdr16∆ fig moreover suppressive effect erg6∆ reduction complex sphingolipid level accumulation cer-c presence aba almost completely abolished pdr16∆ wild-type pdr16∆ cell versus erg6∆ pdr16∆ cell fig effect double deletion pdr16 pdr17 alteration sphingolipid level aba comparable single deletion pdr16 fig thus suggested pdr16 play main role acquisition aba resistance due erg6∆ however single deletion pdr17 weak effect erg6 -deleted cell suggesting pdr17 required pdr16 fully effective aba resistance noted notable difference aba sensitivity observed wild-type pdr16∆ cell fig implying pdr16 confers aba resistance ergosterol biosynthesis impaired pdr16 overexpressed erg6 cell deletion pdr17 also double deletion pdr16 pdr17 pdr16 alone enhanced growth defect aba-treated cell fig however alteration sphingolipid level caused aba affected pdr17∆ pdr16∆ pdr17∆ wild-type versus pdr17∆ pdr16∆ pdr17∆ cell fig suggests pdr17 possibly also pdr16 affect growth defect caused abnormal metabolism complex sphingolipids addition affecting effectiveness aba vivo aur1 activity notion also supported fact tet-aur1 cell deletion pdr17 also double deletion pdr16 pdr17 also enhanced growth defect addition dox fig since pdr17 pdr16 bind phosphatidylinositol facilitate transfer lipid membrane possibility considered pdr17/16 directly interact complex sphingolipids and/or cer deletion pdr17/16 impairs correct sorting sphingolipids within cell consequently result enhancement growth defect repression metabolism complex sphingolipids addition pdr17 together stt4 scs2 pbi1 involved transport phosphatidylserine endosomes affect efficiency conversion phosphatidylserine phosphatidylethanolamine catalyzed endosome-localized psd2 noted aur1 -repressive condition phosphatidylserine phosphatidylethanolamine level decreased thus also important consider function pdr17 phosphatidylserine metabolism affect growth defect impairment metabolism complex sphingolipids suggested pdr16 pdr17 also involved metabolism transport sterol deletion pdr16 and/or pdr17 cause reduction ergosterol level accumulation synthetic intermediate furthermore recently reported vitro assay pdr16 pdr17 facilitate transfer lanosterol ergosterol precursor membrane therefore would important investigate whether function pdr16 pdr17 sterol metabolism transport involved acquisition aba resistance impaired biosynthesis ergosterol however noted vitro transfer activity sterol contribution vivo sterol metabolism significantly different pdr16 pdr17 whereas resistance aba erg6 -deleted cell contribution pdr16 much higher pdr17 fig erg6 -deleted cell protein expression level pdr16 pdr17 posttranslationally upregulated fig thus assumed increased level pdr16 one factor leading acquisition aba resistance via pdr16 however pdr16 expressed cyc1 promoter erg6 -deleted cell exhibited weak resistance aba compared wild-type cell wild-type cell versus cyc1p-pdr16 erg6∆ cell fig although expression pdr16 cyc1 promoter lower native promoter even erg6 deleted fig suggests deletion erg6 contributes pdr16-mediated acquisition aba resistance unknown mechanism addition induction increase pdr16 expression level notable difference localization pdr16 lipid droplet erg6 erg6∆ cell fig deletion erg6 erg2 erg5 cause accumulation synthetic intermediate instead ergosterol total amount sterol reduced possible alteration sterol composition change characteristic lipid droplet may result increase aba resistance-conferring activity pdr16 localized lipid droplet particular fact erg6 localized also lipid droplet may related strong aba resistance conferred erg6∆ doe pdr16 confer resistance aba reported deletion pdr5 double deletion pdr5 yor1 encode plasma membrane-localized abc transporter confers resistance aba possibly regulating permeability aba across plasma membrane addition single deletion yor1 cause aba hypersensitivity however deletion erg6 affect incorporation efficiency aba cell fig furthermore deletion pdr5 enhanced aba resistance erg6 -deleted cell erg6∆ versus erg6∆ pdr5∆ cell erg6∆ yor1∆ cell still exhibited aba resistance compared wild-type cell fig suggesting aba resistance conferred deletion erg6 independent pdr5 yor1 one hypothesis pdr16 restricts accessibility aba aur1 trapping aba confers aba resistance without affecting incorporation efficiency aba cell mutation asp235 lys267 important residue phosphatidylinositol binding activity pdr16 abolishes aba resistance-conferring activity pdr16 suggesting importance lipid binding site acquisition aba resistance therefore evaluation interaction lipid binding site pdr16 aba may important issue assessing mechanism conferring aba resistance mediated pdr16 hand pdr16 -deleted cell exhibit hypersensitivity azole compound expression pdr16 pdr16-e235a k267a pdr16∆ cell complement azole hypersensitivity furthermore pdr16 reduces inhibitory effect azoles vivo activity erg11 target azoles however doe affect efficiency uptake azoles cell consistent fact erg6∆ affect uptake aba fig thus finding may suggest common mechanism confers resistance aba azoles via pdr16 study indicates new connection sphingolipids ergosterol growth defect caused repression expression aur1 lcb1 lip1 enhanced impairment ergosterol biosynthesis pathway fig implying simultaneous abnormal metabolism sphingolipids ergosterol profound effect cell growth whereas impairment ergosterol confers resistance aba affecting effectiveness inhibitor vivo aur1 activity based result assumed order avoid risk simultaneous defect ergosterol sphingolipid metabolism yeast may acquire aba resistance pdr16 condition impaired biosynthesis ergosterol complex sphingolipids ergosterol function together formation lipid microdomains noted can1 tat2 suggested localized lipid microdomains slightly increased deletion erg6 may suggest abnormality lipid microdomains erg6∆ cell fig analysis molecular mechanism underlying aba resistance-conferring activity pdr16 impaired biosynthesis ergosterol provide deeper insight drug-resistance mechanism relationship sphingolipids sterol method yeast strain medium cerevisiae strain used listed table disruption gene performed replacing open reading frame kanmx4 marker pfa6a-kanmx4 hphnt1 marker pfa6a-hphnt1 natnt2 marker pfa6a-natnt2 expression gene constitutive adh cyc1 promoter adh cyc1 promoter cassette containing kanmx4 marker pym-n6 pym-n10 respectively introduced immediately upstream initiator atg chromosomal gene described previously by4741 cell ptetoff-lip1-1 obtained replacing lip1 gene ptetoff-lip1-1 :his3mx6 derived dyy1 cell sey6210.1 ptetoff-lip1-1 :his3mx6 tagging c-terminus aur1 pdr16 nvj1 yeast enhanced green fluorescent protein yegfp red fluorescence protein eqfp611 yegfp fusion cassette hphnt1 marker pym25 eqfp611 fusion cassette kanmx4 marker pym51 introduced immediately upstream stop codon chromosomal gene described previously tagging n-terminus gos1 yeast yegfp tag yegfp fusion cassette adh promoter natnt2 marker pym-n9 introduced immediately downstream initiator atg chromosomal gos1 described previously cell cultured ypd medium yeast extract peptone glucose synthetic complete medium 0.67 yeast nitrogen base without amino acid difco heidelberg germany glucose containing nutritional supplement table strain used study full size table plasmid prs415- pdr16p-mel1 plasmid expressing mel1 control pdr16 promoter region constructed follows 5′-untranslated region pdr16 amplified pcr using primer bamh site 5′-agaggatcctttcaaagacggcggattcaa-3′ primer 5′-tagaaagcaaacattttttgcttttgtaattttttttatataaagtgg-3′ yeast genomic dna template open reading frame mel1 amplified pcr using primer 5′-caaaagcaaaaaatgtttgctttctactttctcac-3′ primer site 5′-agagcggccgcgtggaacaccaacgccacta-3′ pt7blue mel1 provided national bio-resource project nbrp japan template two dna fragment extended pcr fragment obtained digested bamh subcloned prs415 spot assay cell cultured overnight ypd spotted onto ypd agar plate serial tenfold dilution starting density 0.7 units/ml plate incubated photographed day lipid extraction tlc analysis lipid extracted cerevisiae described previously minor modification briefly cell 3.7 detection complex sphingolipids detection cer-c suspended ethanol/water/diethyl ether/pyridine/15 ammonia 15:15:5:1:0.018 v/v incubated min lipid extract centrifuged 10,000 min extracted manner resulting supernatant dried residue dissolved monomethylamine methanol solution 10:3 v/v followed incubation mild alkaline treatment sample dried suspended chloroform/methanol/water 5:4:1 v/v separated silica gel tlc plate merck whitehouse station chloroform/methanol/4.2 ammonia 9:7:2 v/v detection complex sphingolipids chloroform/methanol/acetic acid 100:6:0.6 v/v detection cer-c solvent system tlc plate sprayed copper sulphate orthophosphoric acid heated visualize lipid identification complex sphingolipid cer-c performed described previous paper incorporation c6-nbd-cer cell cell treated c6-nbd-cer thermo fisher scientific waltham usa collected centrifugation washed ice-cold ypd medium containing mg/ml fatty acid-free bsa cell pellet washed twice ice-cold water lipid extracted described except mild alkaline treatment separated tlc plate chloroform/methanol/4.2 ammonia 9:7:2 v/v described fluorescent lipid visualized omega lum aplegen pleasanton usa quantified imagej software lc-esi ms/ms analysis aba cell collected centrifugation washed ice-cold water aba extracted cell described except mild alkaline treatment drying cell extract including aba transferred autoinjector vial aba measured using lc-esi ms/ms qtrap sciex usa equipped inertsustain c18 reverse-phase column 2.1 science tokyo japan gradient started 2-propanol 0.1 formic acid 0.028 ammonium buffer acetonitrile/methanol/distilled water 19:19:2 v/v/v containing 0.1 formic acid 0.028 ammonium reaching min maintained min gradient returned starting condition column equilibrated min next run measurement aba mrm analysis positive ion mode performed following combination q1/q3 1101.8/665.4 1101.8/536.5 collision energy generating product ion peak intensity aba analyzed using multiquant 3.0.1 sciex measurement vitro ipc synthase activity cell unit suspended tris–hcl buffer 9.4 containing 0.28 2-mercaptoethanol incubated room temperature min collected centrifugation cell resuspended tris–hcl buffer 7.5 containing 1.2 sorbitol µg/ml zymolyase 20t nacalai tesque kyoto japan incubated min collected centrifugation spheroplasts lysed sonication buffer tris–hcl buffer 7.5 containing nacl edta protease inhibitor mixture complete™ edta free roche applied science removal cell debris centrifugation min protein content supernatant determined bicinchoninic acid method takara bio shiga japan one nmol c6-nbd-cer phosphatidylinositol soybean nacalai tesque 0.12 0.36 aba added cell lysate containing cell protein buffer following incubation min reaction terminated addition chloroform/methanol 2/1 v/v resultant organic phase dried nbd-lipids separated tlc plate quantified described yeast protein extraction sds-page western blotting protein extraction sds-page western blotting performed described elsewhere modification protein extraction yeast cell grown ypd medium collected centrifugation washed water resuspended 0.2 naoh containing 0.5 2-mercaptoethanol suspension incubated ice min one ice-cold acetone added suspension followed incubation min protein precipitated centrifugation min 10,000 pellet resuspended sample buffer tris–hcl 6.8 containing glycerol 2-mercaptoethanol 0.001 bromophenol blue suspension mixed well heated min centrifuged min 10,000 supernatant separated sds-page according method laemmli western blotting anti-ha sigma-aldrich anti-pgk1 thermo fisher scientific used primary antibody horseradish peroxidase-conjugated anti-mouse igg thermo fisher scientific used secondary antibody enzyme assay α-galactosidase α-galactosidase assay carried described previously briefly cell suspended tris–hcl buffer 7.5 containing 0.35 2-mercaptoethanol 0.002 chloroform added sample vortexed min pre-incubation sample mixed p-nitrophenyl-α-galactoside sigma-aldrich st. louis usa citric acid buffer 4.0 incubated following quenching reaction 0.1 naoh sample centrifuged 10,000 min absorbance supernatant measured statistical analysis statistical analysis performed using student test value obtained indicated